Resverlogix Corp wins Technology Pioneer Award
Research Money, December, 2007 by Anonymous
Resverlogix Corp is the only Canadian recipient of the 23 2008 Technology Pioneer Awards handed out by the World Economic Forum. The Calgary-based firm was recognized for its development of new molecules used in the treatment of atherosclerosis. Cardiovascular disease (CVD) is identified as the number one cause of death globally, with more than 18 million dead annually.
Current therapies address only 30% of the risk associated with CVD and Resverlogix is aiming at the 70% of those still at risk. It was chosen for the award among 273 nominees nominated by venture capital and technology companies from around the world....
Premium Content Partnership |
HighBeam Research provides an in-depth online archive library of reference works.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
